ESCO Ventures X – A*ccelerate PLATINUM grant

Easy grant application with a simplified process

Rapid grant review – less than 3 months from submission to approval

OVERVIEW

The Platinum grant, jointly organised by ESCO Ventures X and A*ccelerate, seeks to demonstrate proof-of-concept for PLATform technologies around biological INsights or Undiscovered Modalities to seed the local biotech ecosystem with innovative scientific substrates.

GRANT AIMS

Platform technologies form the basis of many high-profile biotech companies today and can be considered the basic substrate upon which biotech companies are formed. The aim of the grant is to validate innovative platform technologies by performing key proof-of-concept experiments.

ESCO Ventures X is a biotech venture builder and may elect to co-found a biotech startup with the PI and invest in the startup, if the platform shows promise.

FUNDING PRINCIPLES

Max funding quantum

Up to $450K per project over a preferred period of 1 year and a maximum of 18 months to achieve proof-of-concept for platform technology.

What can be funded

EOM, OOE and EQPT. PI EOM is not fundable.

IP belongs to PI Institution

In the spirit of aiding the biotech ecosystem, ESCO Ventures X has elected to not own any resulting IP from the grant. All IP will belong to the respective Institutions the PIs are in. However, ESCO Ventures X will have first rights to license the foreground IP in order to co-found a startup with the PI.

 

ELIGIBILITY

Platform Technologies

Only platform technologies are eligible. A platform technology can be:

  • Product (therapeutic modality) platform. This is an engine that generates novel new drug modalities. Examples are new viral and non-viral gene therapy delivery vehicle, new gene editing tools, targeting motifs to target anti-sense oligos (ASOs) to new tissue and cell types.

  • Biological insights target discovery platform. This is an engine that is backed by novel, high value insights into diseases and generates previously unappreciated pathways or drug targets in diseases with high unmet need.

*For clarity, single targets will not be considered if it is not part of or arose from a target discovery platform. If the single target arose as part of a platform, the entire platform needs to be presented to be under consideration.

PI Affiliation

Applicants applying as the primary PI must be affiliated with A*STAR. There is a maximum of one co-PI. PIs must have the relevant scientific/technical background and possess necessary experience to direct the project being support by the grant.

IP ownership

Background and any resulting foreground IP should belong solely to public institutions. A*ccelerate must be the IP lead and commercialisation lead.

 

INDICATIVE TIMELINE

STAGE 1

Launch of LOI

Deadline for Submission of LOI

Notification of LOI Shortlisting outcome

24 April 2020

29 May 2020

12 June 2020

STAGE 2

EVX to provide biotech perspective for Full Proposal pitch and POC milestones

Deadline for Submission of Full Proposal

Grant Review Committee may request Revisions to Full Proposal

Submission of revised Full Proposal

Final Panel Showcase: Pitching to Review Panel

Award

22-26 June 2020

10 July 2020

13-17July 2020

23 July 2020

24 July 2020

31 July 2020

*The respective deadlines have been extended by 2 weeks

 

SUBMISSION DETAILS

We understand that PIs are busy. To simplify the process, LOI and Full proposal applications will be in PowerPoint slides. Submissions must follow the grant submission template provided below.

 

Applicants are required to submit their applications by emailing them to platinum@escoventures.com by the appropriate deadlines.

ESSENTIAL DOCUMENTS

1. Introduction to EVX-A*ccelerate PLATINUM Grant

2. LOI submission template

3. Full Proposal submission template

 

CONTACT US

SIGN UP FOR OUR NEWSLETTER

  • LinkedIn - White Circle

SINGAPORE

LaunchPad @ one-north

71 Ayer Rajah Crescent

#03-20/21/23/24

Singapore 139951

UNITED STATES

Cambridge Innovation Center

One Broadway, Kendall Square

Cambridge MA 02142

CHINA

Biotech Innovation Works

No.29 Life Park Road

Room 202-010, Block D

Changping District, Beijing, China, 102206

© 2020 by Esco Ventures Pte. Ltd.